Curcio, R., Frattaruolo, L., Marra, F., Pesole, G., Vozza, A., Cappello, A.R., Fiorillo, M., Lauria, G., Ahmed, A., Fiermonte, G., Capobianco, L., Dolce, V. (2024). Two functionally different mitochondrial phosphate carriers support Drosophila melanogaster OXPHOS throughout distinct developmental stages.  Biochim Biophys Acta Mol Cell Res 1871(1): 119615.

FBrf0258133

Research paper

The mitochondrial oxidative phosphorylation system (OXPHOS) plays a central role in cellular energy metabolism by producing ATP. In this study, an in silico analysis conducted on nuclear somatically expressed Drosophila melanogaster OXPHOS genes, revealed shared features including widespread expression, presence of Nuclear Respiratory Gene (NRG) elements, and coordinated developmental-dependent expression, with two distinct peaks of expression during late embryonic and pupal stages. In contrast, OXPHOS paralog genes showed a unique pupal peak and were primarily expressed in adult testes. Furthermore, we conducted an extensive characterization of D. melanogaster mitochondrial phosphate carrier (Mpcp), a key player of OXPHOS. In Drosophila two genes, CG9090 and CG4994, encode putative Mpcp known as Mpcp1 and Mpcp2. Intriguingly, the expression patterns of Mpcps during development exhibited significant differences from each other and from those of other OXPHOS genes. This suggests that both isoforms contribute to ATP synthesis and are essential for the full organism development, with CG9090 also showing a connection with lifespan and aging processes. Functional complementation assays, swelling experiments carried out in the yeast mir1∆ strain and an extensive kinetic characterization of recombinant mature Mpcp2 confirmed that both isoforms transport phosphate. However, Mpcp1 displays a three folds lower activity compared to Mpcp2. Collectively, these findings suggest that mMpcp1 and mMpcp2 operate similarly to mammalian PiC-A and PiC-B, respectively. This provides a basis for exploring functional differences in mammals and gaining new insights into the mechanisms underlying OXPHOS-related diseases associated to deficiencies in human PiC transporters.